Tag: Alzheimer’s
New Criteria Developed for Appropriate Use of Amyloid, Tau PET
17 clinical scenarios developed for which amyloid or tau PET may be considered
Dementia Index Shows Validity for Predicting Age of Onset of MCI, Alzheimer Disease
In simulated trial, FDI achieved mean absolute errors of 1.57 and 0.70 years for predicting MCI, AD onset, respectively
Recommendations Developed for Evaluation of Patients With Alzheimer Disease
Clinical practice guideline also presents recommendations for specialist care and primary care of patients with Alzheimer disease, dementia
Early Bilateral Oophorectomy Increases Risk of Alzheimer Disease
Risk even higher among women with bilateral oophorectomy carrying an APOE4 allele
RSNA: Obesity, VAT Linked to Measures of Amyloid Burden in Midlife
Visceral adipose tissue had significant direct effect on amyloid burden, which was not explained by HOMA-IR
Worse Outcomes Seen for Seniors With Alzheimer Disease, Dementia, Polypharmacy
Older adults with ADRD and polypharmacy experience more symptoms, have negative health outcomes
Semaglutide Linked to Reduced Risk for Alzheimer Diagnosis in T2DM
Semaglutide linked to significantly reduced risk, most strongly compared with insulin and most weakly with other GLP-1 RAs
ED Visit Rate 36.1 per 1,000 Older Adults With Alzheimer Disease
Ambulance arrival was more frequent for emergency department visits made by adults with versus without Alzheimer disease
Dronabinol Safe, Effective for Alzheimer Disease With Agitation
Authors are optimistic about the 'repurposing' of FDA-approved dronabinol
SGLT2i Use Linked to Lower Risk for Neurodegenerative Disease in T2DM
Reduced risk for Alzheimer disease, vascular dementia, and Parkinson disease seen with SGLT2i use in type 2 diabetes